SteelPeak Wealth LLC Sells 138,000 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

SteelPeak Wealth LLC reduced its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 20.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 541,984 shares of the company's stock after selling 138,000 shares during the quarter. Astrana Health makes up approximately 0.7% of SteelPeak Wealth LLC's holdings, making the stock its 28th largest holding. SteelPeak Wealth LLC owned about 0.96% of Astrana Health worth $17,089,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. State Street Corp bought a new position in Astrana Health in the third quarter valued at approximately $91,966,000. Geode Capital Management LLC bought a new position in shares of Astrana Health during the 3rd quarter worth approximately $58,995,000. FMR LLC acquired a new stake in Astrana Health in the 3rd quarter valued at $48,413,000. Loomis Sayles & Co. L P bought a new position in shares of Astrana Health in the 3rd quarter valued at about $30,251,000. Finally, NorthCrest Asset Manangement LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $26,704,000. Institutional investors own 52.77% of the company's stock.

Astrana Health Price Performance

ASTH stock traded up $0.05 during trading on Friday, reaching $36.87. 315,669 shares of the company were exchanged, compared to its average volume of 367,344. The company has a 50-day moving average of $36.27 and a two-hundred day moving average of $46.34. The company has a market capitalization of $2.07 billion, a price-to-earnings ratio of 28.36, a P/E/G ratio of 1.42 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health, Inc. has a twelve month low of $29.08 and a twelve month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts' consensus estimates of $0.33. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the previous year, the firm earned $0.47 earnings per share. As a group, equities analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on ASTH. TD Cowen assumed coverage on Astrana Health in a research note on Monday, October 14th. They issued a "buy" rating and a $66.00 price objective on the stock. KeyCorp initiated coverage on Astrana Health in a report on Friday, October 11th. They issued a "sector weight" rating for the company. Truist Financial decreased their target price on shares of Astrana Health from $59.00 to $50.00 and set a "buy" rating on the stock in a report on Monday, January 13th. Macquarie raised shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. Finally, Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $63.67.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.